Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hagop M Kantarjian

Showing results (1-10 of 718) with videos related to

Pageof 72
Sort By:
International Journal of Hematology|June 8, 2006
New strategies in chronic myeloid leukemiaHagop M Kantarjian, Jorge Cortes
Cancer|July 9, 2004
Novel therapies for myelodysplastic syndromesStefan Faderl, Hagop M Kantarjian
Nature Clinical Practice. Oncology|August 4, 2005
Drug insight: emerging new drugs in the treatment of myelodysplastic syndromesStefan Faderl, Hagop M Kantarjian
Journal of Oncology Practice|June 4, 2015
Role of the 340B Drug Discount Program in Recent Cancer Care TrendsHagop M Kantarjian, Robert Chapman
Oncology (Williston Park, N.Y.)|October 27, 1997
Biology and treatment of chronic myelogenous leukemiaFrancis J Giles, Hagop M Kantarjian
Oncology (Williston Park, N.Y.)|March 18, 1999
Chronic myelogenous leukemia: update on biology and treatmentStefan Faderl, Hagop M Kantarjian, Moshe Talpaz
Seminars in Hematology|July 15, 2005
Decitabine dosing schedulesHagop M Kantarjian, Jean-Pierre J Issa
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2013
Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approvalHagop M Kantarjian, Susan O'Brien, Jorge Cortes
Nature Reviews. Clinical Oncology|December 17, 2014
Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatmentJesús F San-Miguel, Hagop M Kantarjian
Cancer|September 26, 2003
The biology and therapy of adult acute lymphoblastic leukemiaStefan Faderl, Sima Jeha, Hagop M Kantarjian
Pageof 72

Showing results (1-10 of 718) with videos related to

Sort By:
Pageof 72
International Journal of Hematology|June 8, 2006
New strategies in chronic myeloid leukemiaHagop M Kantarjian, Jorge Cortes
Cancer|July 9, 2004
Novel therapies for myelodysplastic syndromesStefan Faderl, Hagop M Kantarjian
Nature Clinical Practice. Oncology|August 4, 2005
Drug insight: emerging new drugs in the treatment of myelodysplastic syndromesStefan Faderl, Hagop M Kantarjian
Journal of Oncology Practice|June 4, 2015
Role of the 340B Drug Discount Program in Recent Cancer Care TrendsHagop M Kantarjian, Robert Chapman
Oncology (Williston Park, N.Y.)|October 27, 1997
Biology and treatment of chronic myelogenous leukemiaFrancis J Giles, Hagop M Kantarjian
Oncology (Williston Park, N.Y.)|March 18, 1999
Chronic myelogenous leukemia: update on biology and treatmentStefan Faderl, Hagop M Kantarjian, Moshe Talpaz
Seminars in Hematology|July 15, 2005
Decitabine dosing schedulesHagop M Kantarjian, Jean-Pierre J Issa
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2013
Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approvalHagop M Kantarjian, Susan O'Brien, Jorge Cortes
Nature Reviews. Clinical Oncology|December 17, 2014
Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatmentJesús F San-Miguel, Hagop M Kantarjian
Cancer|September 26, 2003
The biology and therapy of adult acute lymphoblastic leukemiaStefan Faderl, Sima Jeha, Hagop M Kantarjian
Pageof 72